These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Vancomycin: pharmacokinetics and administration regimens in neonates. de Hoog M, Mouton JW, van den Anker JN. Clin Pharmacokinet; 2004; 43(7):417-40. PubMed ID: 15139793 [Abstract] [Full Text] [Related]
27. The Whole Price of Vancomycin: Toxicities, Troughs, and Time. Jeffres MN. Drugs; 2017 Jul; 77(11):1143-1154. PubMed ID: 28573434 [Abstract] [Full Text] [Related]
28. Evaluation of risk factors for vancomycin-induced nephrotoxicity. Park SJ, Lim NR, Park HJ, Yang JW, Kim MJ, Kim K, In YW, Lee YM. Int J Clin Pharm; 2018 Oct; 40(5):1328-1334. PubMed ID: 29744794 [Abstract] [Full Text] [Related]
31. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A. Eur J Clin Pharmacol; 2012 Sep; 68(9):1243-55. PubMed ID: 22411630 [Abstract] [Full Text] [Related]
32. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients. Chuma M, Makishima M, Imai T, Tochikura N, Suzuki S, Kuwana T, Sawada N, Komatsu T, Sakaue T, Kikuchi N, Yoshida Y, Kinoshita K. Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798 [Abstract] [Full Text] [Related]
38. Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study. Bhatt-Mehta V, Schumacher RE, Faix RG, Leady M, Brenner T. Pediatrics; 1999 Apr; 103(4):e48. PubMed ID: 10103340 [Abstract] [Full Text] [Related]